文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

白细胞介素-1受体2:脓毒症诊断及革兰阴性/阳性细菌鉴别的新生物标志物

Interleukin-1 Receptor 2: A New Biomarker for Sepsis Diagnosis and Gram-Negative/Gram-Positive Bacterial Differentiation.
PubMed 文献 · Shock · 2017-01-01
一句话结论在脓毒症患者中,血清IL1R2对脓毒症诊断及革兰阴性/阳性细菌鉴别的敏感度和特异度优于PCT、CRP和APACHE II评分。

研究在昆明小鼠和脓毒症患者中探索IL1R2作为脓毒症诊断及革兰阴性/阳性细菌鉴别生物标志物的价值。小鼠用灭活大肠埃希菌或金黄色葡萄球菌刺激(10 CFU/kg),临床研究纳入不同病原体感染的脓毒症患者,并以健康志愿者和无明确感染的系统性炎症反应综合征患者为对照。结果显示IL1R2在灭活大肠埃希菌处理的小鼠和脓毒症患者中表达上调,且大肠埃希菌或革兰阴性菌感染者的血清IL1R2升高较金黄色葡萄球菌或革兰阳性菌感染者更显著。ROC曲线显示血清IL1R2对脓毒症诊断和革兰阴性/阳性细菌鉴别的敏感度和特异度优于PCT、CRP和APACHE II等传统标志物。作者认为IL1R2是脓毒症诊断及革兰阴性/阳性细菌鉴别的潜在生物标志物。

要点

  • 脓毒症患者外周血白细胞IL1R2转录水平及血清IL1R2浓度上调,且在灭活大肠埃希菌刺激的小鼠中同样上调。
  • 大肠埃希菌或革兰阴性菌感染的脓毒症患者血清IL1R2升高程度大于金黄色葡萄球菌或革兰阳性菌感染者。
  • ROC曲线显示血清IL1R2对脓毒症诊断的敏感度和特异度优于PCT、CRP和APACHE II评分。
  • ROC曲线显示血清IL1R2对革兰阴性/阳性细菌脓毒症鉴别的敏感度和特异度优于PCT、CRP和APACHE II评分。

适用人群与场景

  • 临床研究纳入不同病原体感染的脓毒症患者,并以健康志愿者和无明确感染的系统性炎症反应综合征患者为对照;动物实验使用昆明小鼠。

研究设计与关键结果

  • 研究在昆明小鼠和脓毒症患者中进行,小鼠用灭活大肠埃希菌或金黄色葡萄球菌刺激(10 CFU/kg),临床研究比较不同病原体感染的脓毒症患者与健康志愿者及无明确感染的系统性炎症反应综合征患者。
  • IL1R2在灭活大肠埃希菌处理的小鼠和脓毒症患者中表达上调。
  • 血清IL1R2升高在大肠埃希菌或革兰阴性菌感染的脓毒症患者中比在金黄色葡萄球菌或革兰阳性菌感染者中更显著。
  • ROC曲线显示,血清IL1R2对脓毒症诊断和革兰阴性/阳性细菌脓毒症鉴别的敏感度和特异度优于PCT、CRP和APACHE II。

证据类型、等级与局限

  • 证据类型:动物实验联合临床病例对照研究;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为IL1R2是脓毒症诊断及革兰阴性/阳性细菌鉴别的潜在生物标志物。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

This study was undertaken to explore the value of interleukin-1 receptor 2 (IL1R2) as a novel potential biomarker for diagnosis of sepsis and discrimination of gram-negative (G)/gram-positive (G) bacterial sepsis. The study was performed in Kunming mice and septic patients. Inactive Escherichia coli or Staphylococcus aureus were used to stimulate Kunming mice (10 CFU/kg). In clinical study, septic patients with different pathogen infection were studied, and healthy volunteers and patients with systemic inflammatory response syndrome without definite infection were enrolled as control. IL1R2 transcriptions of human subjects' peripheral leukocytes were measured by real-time quantitative polymerase chain reaction assay. IL1R2 serum concentrations of mice and human subjects were measured by enzyme-linked immunosorbent assay. The value of IL1R2 as a biomarker was compared with procalcitonin (PCT), C-reactive protein (CRP), and Acute Physiology and Chronic Health Evaluation II (APACHE II). The results showed that IL1R2 expression was upregulated in mice treated with inactive Escherichia coli and septic patients. The elevation of serum IL1R2 was more significant in septic patients infected by Escherichia coli or G bacteria than in those infected by Staphylococcus aureus or G bacteria. For sepsis diagnosis and G/G bacterial sepsis discrimination, serum IL1R2 was more sensitive and specific than the traditional biomarkers such as PCT, CRP, and APACHE II as shown by the receiver operating characteristic curves. It was suggested that IL1R2 was a potential biomarker for diagnosis and G/G bacterial differentiation in sepsis.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Lang Y, Jiang Y, Gao M, et al. Interleukin-1 Receptor 2: A New Biomarker for Sepsis Diagnosis and Gram-Negative/Gram-Positive Bacterial Differentiation. Shock. 2017. PMID: 27984536

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。